AbstractGet full access to this articleView all access options for this article.Get accessReferences1. Kantarjian H. , Capdeville R. , Ohno-Jones S. , Sawyers CL Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344(14): 1031-37.
